326 related articles for article (PubMed ID: 37310269)
41. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
Guo LN; Xiao M; Cao B; Qu F; Zhan YL; Hu YJ; Wang XR; Liang GW; Gu HT; Qi J; Yuan H; Min R; Wang FY; Liu LJ; Wang HB; Jiang W; Duan XG; Xu WJ; Yu YH; Su JR; Zhang JZ; Nong JQ; Liu SM; Li J; Liu JT; Yue ZG; Yang D; Guo J; Zhao R; Zhang YN; Yang XM; Liu XQ; Hsueh PR; Xu YC
Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
[TBL] [Abstract][Full Text] [Related]
42. Candida bloodstream infection among children hospitalised in three public-sector hospitals in the Metro West region of Cape Town, South Africa.
Gebremicael MN; Nuttall JJC; Tootla HD; Khumalo A; Tooke L; Salie S; Muloiwa R; Rhoda N; Basera W; Eley BS
BMC Infect Dis; 2023 Feb; 23(1):67. PubMed ID: 36737689
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China.
Ding X; Yan D; Sun W; Zeng Z; Su R; Su J
Med Mycol; 2015 Sep; 53(7):684-90. PubMed ID: 26229153
[TBL] [Abstract][Full Text] [Related]
44. Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance.
da Silva CM; de Carvalho AMR; Macêdo DPC; Jucá MB; Amorim RJM; Neves RP
Braz J Microbiol; 2023 Jun; 54(2):817-825. PubMed ID: 36892755
[TBL] [Abstract][Full Text] [Related]
45. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
[TBL] [Abstract][Full Text] [Related]
46. Candidemia Cases Caused by Candida parapsilosis Complex Species: Epidemiology and Antifungal Susceptibility of Strains.
Cetinkaya O; Ozyurt OK; Kuskucu MA; Ozhak B; Ongut G; Yazisiz H; Ogunc D
Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084692
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai.
Yang ZT; Wu L; Liu XY; Zhou M; Li J; Wu JY; Cai Y; Mao EQ; Chen EZ; Lortholary O
BMC Infect Dis; 2014 May; 14():241. PubMed ID: 24886130
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of candidemia in children at a university hospital: A retrospective cohort.
Guner Ozenen G; Sahbudak Bal Z; Avcu G; Ozkaya Yazici P; Karakoyun M; Metin DY; Hilmioglu Polat S
Mycoses; 2023 May; 66(5):367-377. PubMed ID: 36597951
[TBL] [Abstract][Full Text] [Related]
49. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.
Bassetti M; Merelli M; Righi E; Diaz-Martin A; Rosello EM; Luzzati R; Parra A; Trecarichi EM; Sanguinetti M; Posteraro B; Garnacho-Montero J; Sartor A; Rello J; Tumbarello M
J Clin Microbiol; 2013 Dec; 51(12):4167-72. PubMed ID: 24108614
[TBL] [Abstract][Full Text] [Related]
51. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
Pfaller MA; Moet GJ; Messer SA; Jones RN; Castanheira M
Antimicrob Agents Chemother; 2011 Feb; 55(2):561-6. PubMed ID: 21115790
[TBL] [Abstract][Full Text] [Related]
52. Candidemia in Internal Medicine: Facing the New Challenge.
Brescini L; Mazzanti S; Morroni G; Pallotta F; Masucci A; Orsetti E; Montalti R; Barchiesi F
Mycopathologia; 2022 Jun; 187(2-3):181-188. PubMed ID: 35298733
[TBL] [Abstract][Full Text] [Related]
53. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
54. The Epidemiology and Susceptibility of Candidemia in Jerusalem, Israel.
Israel S; Amit S; Israel A; Livneh A; Nir-Paz R; Korem M
Front Cell Infect Microbiol; 2019; 9():352. PubMed ID: 31681629
[No Abstract] [Full Text] [Related]
55. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
[TBL] [Abstract][Full Text] [Related]
57. Analysis of candidemia cases in a city hospital during the COVID-19 pandemic.
Ozalp O; Komec S; Unsel M; Gunduz A; Altuntas Aydin O
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2558-2568. PubMed ID: 38567615
[TBL] [Abstract][Full Text] [Related]
58. [Candidemia in an intensive care unit].
Adukauskiene D; Kinderyte A; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2009; 45(5):351-6. PubMed ID: 19535880
[TBL] [Abstract][Full Text] [Related]
59. Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan.
Morii D; Seki M; Binongo JN; Ban R; Kobayashi A; Sata M; Hashimoto S; Shimizu J; Morita S; Tomono K
J Infect Chemother; 2014 Sep; 20(9):558-62. PubMed ID: 25009091
[TBL] [Abstract][Full Text] [Related]
60. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
Li Y; Du M; Chen LA; Liu Y; Liang Z
Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
